127 related articles for article (PubMed ID: 30409896)
1. B & B: basophils and bleeding, an atypical case of acute promyelocytic leukemia.
Lebecque B; Lechevalier N
Blood; 2018 Nov; 132(19):2107. PubMed ID: 30409896
[No Abstract] [Full Text] [Related]
2. Basophil-lineage commitment in acute promyelocytic leukemia predicts for severe bleeding after starting therapy.
Matarraz S; Leoz P; Fernández C; Colado E; Chillón MC; Vidriales MB; González M; Rivera D; Osuna CS; Caballero-Velázquez T; Van Der Velden V; Jongen-Lavrencic M; Gutiérrez O; Bermejo AY; Alonso LG; García MB; De Ramón Sánchez C; García-Donas G; Mateo AG; Recio I; Sánchez-Real J; Mayado A; Gutiérrez ML; Bárcena P; Barrena S; López A; Van Dongen J; Orfao A
Mod Pathol; 2018 Aug; 31(8):1318-1331. PubMed ID: 29572500
[TBL] [Abstract][Full Text] [Related]
3. Translocations t(15;17) and t(9;14)(q34;q22) in a case of acute promyelocytic leukemia with increased number of basophils.
Gotoh H; Murakami S; Oku N; Itoh K; Takeda N; Fujita N; Shimazaki C; Nishio A; Haruyama H; Nakagawa M
Cancer Genet Cytogenet; 1988 Nov; 36(1):103-7. PubMed ID: 3203292
[TBL] [Abstract][Full Text] [Related]
4. Acute promyelocytic leukaemia with increased basophils.
Zhang J; Li M; He Y
Br J Haematol; 2019 Apr; 185(1):7. PubMed ID: 30426468
[No Abstract] [Full Text] [Related]
5. Hemorrhage in acute promyelocytic leukemia: Can it be predicted and prevented?
Naymagon L; Mascarenhas J
Leuk Res; 2020 Jul; 94():106356. PubMed ID: 32445941
[TBL] [Abstract][Full Text] [Related]
6. Medium pH determines the differentiation of human promyelocytic leukemia cells to basophils or eosinophils by culturing in a protein- and serum-free medium.
Muroi K; Sasaki R; Miura Y; Ohyashiki K
Leuk Res; 1989; 13(2):157-63. PubMed ID: 2927173
[TBL] [Abstract][Full Text] [Related]
7. Evidence for basophilic differentiation of acute promyelocytic leukaemia cells during arsenic trioxide therapy.
Masamoto Y; Nannya Y; Arai S; Koike Y; Hangaishi A; Yatomi Y; Kurokawa M
Br J Haematol; 2009 Mar; 144(5):798-9. PubMed ID: 19036092
[No Abstract] [Full Text] [Related]
8. Early hemorrhagic death before starting therapy in acute promyelocytic leukemia: association with high WBC count, late diagnosis and delayed treatment initiation.
Breccia M; Latagliata R; Cannella L; Minotti C; Meloni G; Lo-Coco F
Haematologica; 2010 May; 95(5):853-4. PubMed ID: 20015875
[No Abstract] [Full Text] [Related]
9. Predictors of early hemorrhage in acute promyelocytic leukemia.
Naymagon L; Moshier E; Tremblay D; Mascarenhas J
Leuk Lymphoma; 2019 Oct; 60(10):2394-2403. PubMed ID: 30849255
[TBL] [Abstract][Full Text] [Related]
10. Severe hemorrhagic complications during remission induction therapy for acute promyelocytic leukemia: incidence, risk factors, and influence on outcome.
Yanada M; Matsushita T; Asou N; Kishimoto Y; Tsuzuki M; Maeda Y; Horikawa K; Okada M; Ohtake S; Yagasaki F; Matsumoto T; Kimura Y; Shinagawa K; Iwanaga M; Miyazaki Y; Ohno R; Naoe T
Eur J Haematol; 2007 Mar; 78(3):213-9. PubMed ID: 17241371
[TBL] [Abstract][Full Text] [Related]
11. Acute promyelocytic leukaemia with promyelocyte count below 20.
Jiang X; Zhang L; Zhou D
Br J Haematol; 2016 Apr; 173(1):11. PubMed ID: 26708693
[No Abstract] [Full Text] [Related]
12. Basophilic differentiation in acute promyelocytic leukemia.
Tallman MS; Hakimian D; Snower D; Rubin CM; Reisel H; Variakojis D
Leukemia; 1993 Apr; 7(4):521-6. PubMed ID: 7710454
[TBL] [Abstract][Full Text] [Related]
13. Prophylaxis of symptoms of hyperhistaminemia after the treatment of acute promyelocytic leukemia with all-trans retinoic acid.
Shimamoto Y; Suga K; Yamaguchi M; Kuriyama K; Tomonaga M
Acta Haematol; 1994; 92(2):109-12. PubMed ID: 7817703
[TBL] [Abstract][Full Text] [Related]
14. Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia.
Chang H; Kuo MC; Shih LY; Dunn P; Wang PN; Wu JH; Lin TL; Hung YS; Tang TC
Eur J Haematol; 2012 Apr; 88(4):321-8. PubMed ID: 22221178
[TBL] [Abstract][Full Text] [Related]
15. Marked basophilia in acute promyelocytic leukaemia treated with all-trans retinoic acid: molecular analysis of the cell origin of the basophils.
Iwakiri R; Inokuchi K; Dan K; Nomura T
Br J Haematol; 1994 Apr; 86(4):870-2. PubMed ID: 7918086
[TBL] [Abstract][Full Text] [Related]
16. Increased promyelocytic-derived microparticles: a novel potential factor for coagulopathy in acute promyelocytic leukemia.
Ma G; Liu F; Lv L; Gao Y; Su Y
Ann Hematol; 2013 May; 92(5):645-52. PubMed ID: 23344645
[TBL] [Abstract][Full Text] [Related]
17. Update on the management of pediatric acute promyelocytic leukemia.
Feusner J; Gregory JJ
Clin Adv Hematol Oncol; 2006 Nov; 4(11):854-5; author reply 855-6. PubMed ID: 17193721
[No Abstract] [Full Text] [Related]
18. Acute promyelocytic leukaemia with marked symptomatic hyperleucocytosis.
Yuan Y; Mediwake H; Bokhari SW; Holley A; Lane SW
Br J Haematol; 2019 Sep; 186(5):649. PubMed ID: 31219172
[No Abstract] [Full Text] [Related]
19. Brief report: severe symptoms of hyperhistaminemia after the treatment of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).
Koike T; Tatewaki W; Aoki A; Yoshimoto H; Yagisawa K; Hashimoto S; Furukawa T; Saitoh H; Takahashi M; Yang LB
N Engl J Med; 1992 Aug; 327(6):385-7. PubMed ID: 1625712
[No Abstract] [Full Text] [Related]
20. Treatment of acute myeloid leukemia M3 in a patient with Crohn's disease.
Harewood G; Markovic S
Cancer Invest; 2000; 18(1):98. PubMed ID: 10701373
[No Abstract] [Full Text] [Related]
[Next] [New Search]
